接受抗TNF-α治疗的患者出现的生殖器人乳头瘤病毒病变和传染性软疣。 - Suppr

Suppr

超能文献

Genital HPV lesions and molluscum contagiosum occurring in patients receiving anti-TNF-alpha therapy.

作者信息

Antoniou Christina, Kosmadaki Maria G, Stratigos Alexandros J, Katsambas Andreas D

出版信息

Dermatology. 2008;216(4):364-5. doi: 10.1159/000117709. Epub 2008 Feb 20.

DOI:10.1159/000117709

PMID:18285688

Abstract

摘要

相似文献

Genital HPV lesions and molluscum contagiosum occurring in patients receiving anti-TNF-alpha therapy.

Dermatology. 2008;216(4):364-5. doi: 10.1159/000117709. Epub 2008 Feb 20.

Anti-tumor necrosis factor alpha therapy in psoriatic arthritis and psoriasis.

Arch Dermatol. 2001 Jun;137(6):784-5.

[Psoriasis and psoriatic rheumatism: effectiveness of etanercept for cutaneous and joint lesions].

Ann Dermatol Venereol. 2010 Apr;137(4 Suppl):13-5. doi: 10.1016/S0151-9638(10)70012-0.

Guideline for anti-TNF-alpha therapy in psoriatic arthritis.

Rheumatology (Oxford). 2005 Mar;44(3):390-7. doi: 10.1093/rheumatology/keh514. Epub 2005 Feb 3.

TNFalpha therapy in psoriatic arthritis and psoriasis.

Ann Rheum Dis. 2004 Jul;63(7):755-8. doi: 10.1136/ard.2004.020719.

Psoriasis exacerbation after a flu-like syndrome during anti-TNF-alpha therapy.

Eur J Dermatol. 2006 May-Jun;16(3):316-7.

Etanercept: An overview.

J Am Acad Dermatol. 2003 Aug;49(2 Suppl):S105-11. doi: 10.1016/mjd.2003.554.

Safety of antitumour necrosis factor-α therapy in psoriatic patients with hepatitis B virus infection.

Br J Dermatol. 2010 Jun;162(6):1408-10. doi: 10.1111/j.1365-2133.2010.09714.x. Epub 2010 Feb 22.

Etanercept for psoriasis: two case reports.

Int J Clin Pharmacol Res. 2005;25(4):159-63.

[Development of systemic lupus erythematosus with focal proliferative lupus nephritis during anti-TNF-alpha therapy for psoriatic arthritis].

Med Klin (Munich). 2007 Oct 15;102(10):852-7. doi: 10.1007/s00063-007-1104-6.

引用本文的文献

Anti-Tumor Necrosis Factor-α Use in Pediatric Inflammatory Bowel Disease-Reports from a Romanian Center.

Pharmaceuticals (Basel). 2025 Jan 11;18(1):84. doi: 10.3390/ph18010084.

Genital Dysplasia and Immunosuppression: Why Organ-Specific Therapy Is Important.

Inflamm Intest Dis. 2019 Oct;4(4):154-160. doi: 10.1159/000502687. Epub 2019 Sep 17.

Multidisciplinary, evidence-based consensus guidelines for human papillomavirus (HPV) vaccination in high-risk populations, Spain, 2016.

Euro Surveill. 2019 Feb;24(7). doi: 10.2807/1560-7917.ES.2019.24.7.1700857.

Acquired epidermodysplasia verruciformis in setting of tumor necrosis factor-α inhibitor therapy.

JAAD Case Rep. 2018 Sep 14;4(8):805-807. doi: 10.1016/j.jdcr.2018.05.021. eCollection 2018 Sep.

HPV-Positive Oropharyngeal Squamous Cell Carcinoma among Patients Taking Adalimumab for Autoimmune Disorders.

Otolaryngol Head Neck Surg. 2018 Sep;159(3):593-594. doi: 10.1177/0194599818774756. Epub 2018 May 8.

Squamous cell carcinoma of the rectum: a consequence of immunosuppression resulting from inhibiting tumour necrosis factor (TNF)?

Ecancermedicalscience. 2016 Jun 7;10:646. doi: 10.3332/ecancer.2016.646. eCollection 2016.

Cumulative incidence of, risk factors for, and outcome of dermatological complications of anti-TNF therapy in inflammatory bowel disease: a 14-year experience.

Am J Gastroenterol. 2015 Aug;110(8):1186-96. doi: 10.1038/ajg.2015.205. Epub 2015 Jul 21.

Human papillomavirus and chlamydia trachomatis infections in rheumatoid arthritis under anti-TNF therapy: an observational study.

Rheumatol Int. 2015 Mar;35(3):459-63. doi: 10.1007/s00296-014-3157-1. Epub 2014 Oct 28.

Eruptive condyloma accuminata after initiation of infliximab treatment for folliculitis decalvans.

Case Rep Dermatol Med. 2013;2013:762035. doi: 10.1155/2013/762035. Epub 2013 Dec 4.

Prevention of infection caused by immunosuppressive drugs in gastroenterology.

Ther Adv Chronic Dis. 2013 Jul;4(4):167-85. doi: 10.1177/2040622313485275.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验